Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1991-11-13
|
pubmed:abstractText |
The serum, urine and tissue concentrations of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT), 5-fluorouracil (5-FU) and uracil were estimated in 11 patients with prostate cancer (4 cases treated by total prostatectomy and 7 cases by transurethral resection (TUR-P) after oral administration of UFT. The concentration of FT, 5-FU and uracil in the tumor tissue (micrograms/g) were 5.920 +/- 5.902, 0.018 +/- 0.012 (T/S; 2.20) and 7.785 +/- 4.151 in 4 patients treated by total prostatectomy and 1.943 +/- 1.355, 0.024 +/- 0.010 (T/S; 1.46) and 4.616 +/- 2.848 in 7 patients treated by transurethral resection of prostate. The concentrations of FT, 5-FU and uracil in the tumor tissue did not increase as compared with those in normal tissue in 4 cases treated by total prostatectomy.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0018-1994
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
711-5
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:1927771-Administration, Oral,
pubmed-meshheading:1927771-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:1927771-Fluorouracil,
pubmed-meshheading:1927771-Humans,
pubmed-meshheading:1927771-Male,
pubmed-meshheading:1927771-Prostatectomy,
pubmed-meshheading:1927771-Prostatic Neoplasms,
pubmed-meshheading:1927771-Tegafur,
pubmed-meshheading:1927771-Uracil
|
pubmed:year |
1991
|
pubmed:articleTitle |
[Studies on 5-FU concentration in serum and prostate cancer tissue after oral administration of UFT].
|
pubmed:affiliation |
Department of Urology, Gifu University School of Medicine.
|
pubmed:publicationType |
Journal Article,
English Abstract
|